LeterMovir
(1)
Letermovir (917389-32-3)
Preis: Negotiable
MOQ: Negotiable
Lieferzeit: Negotiable
Markieren:Letermovir 917389-32-3, 99% Lletermovir prophylaxis, CAS: 917389-32-3 Letermovir API
Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. Product Name: Letermovir CAS No.: 917389-32-3 Assay: 99% Specification: CP, EP, In-house, a... Mehr sehen
➤ Besuch Webseite